Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (JPRN-UMIN000058428) titled 'Additive effect of P2X3 inhibitor, gefapixant, on azelastin for refractory atopic cough' on Sept. 30.
Study Type: Observational
Study Design:
Not selected Not selected
Primary Sponsor: Respiratory and Allergy Medicine, Kansai Medial University
Condition:
Atopic cough
Recruitment Status: Recruiting
Phase: Not selected
Date of First Enrollment: 2022/04/01
Target Sample Size: 30
Countries of Recruitment:
Japan
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066806
Published by HT Digital Content Services with permission from Health Daily Digest....